HUT55352A - Process for producing compounds inhibiting cholesterol ester hydrolase enzyme and pharmaceutical compositions comprising such compounds - Google Patents

Process for producing compounds inhibiting cholesterol ester hydrolase enzyme and pharmaceutical compositions comprising such compounds

Info

Publication number
HUT55352A
HUT55352A HU907132A HU713290A HUT55352A HU T55352 A HUT55352 A HU T55352A HU 907132 A HU907132 A HU 907132A HU 713290 A HU713290 A HU 713290A HU T55352 A HUT55352 A HU T55352A
Authority
HU
Hungary
Prior art keywords
compounds
pharmaceutical compositions
cholesterol ester
ester hydrolase
hydrolase enzyme
Prior art date
Application number
HU907132A
Other languages
English (en)
Other versions
HU207842B (en
Inventor
Richard Eric Newshaw
Thomas Joseph Commons
Donald Peter Strike
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909005537A external-priority patent/GB9005537D0/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of HUT55352A publication Critical patent/HUT55352A/hu
Publication of HU207842B publication Critical patent/HU207842B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/36—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU907132A 1989-11-15 1990-11-15 Process for producing compounds inhibiting cholesterol-ester-hydrolase enzyme and pharmaceutical compositions containing this enzyme HU207842B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43684189A 1989-11-15 1989-11-15
GB909005537A GB9005537D0 (en) 1990-03-12 1990-03-12 Cholesterol ester hydrolase inhibitors
US59424190A 1990-10-09 1990-10-09

Publications (2)

Publication Number Publication Date
HUT55352A true HUT55352A (en) 1991-05-28
HU207842B HU207842B (en) 1993-06-28

Family

ID=27264978

Family Applications (1)

Application Number Title Priority Date Filing Date
HU907132A HU207842B (en) 1989-11-15 1990-11-15 Process for producing compounds inhibiting cholesterol-ester-hydrolase enzyme and pharmaceutical compositions containing this enzyme

Country Status (12)

Country Link
EP (1) EP0428385A1 (hu)
JP (1) JPH03206071A (hu)
KR (1) KR910009644A (hu)
AU (1) AU635087B2 (hu)
CA (1) CA2029934A1 (hu)
FI (1) FI905558L (hu)
GB (1) GB2238542B (hu)
HU (1) HU207842B (hu)
IE (1) IE904114A1 (hu)
IL (1) IL95994A0 (hu)
NZ (1) NZ236061A (hu)
PT (1) PT95869A (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169844A (en) * 1991-12-20 1992-12-08 American Home Products Corporation 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption
US5952354A (en) * 1993-07-21 1999-09-14 American Home Products Corporation Tris carbamic acid esters: inhibitors of cholesterol absorption
US5527804A (en) * 1994-06-13 1996-06-18 American Home Products Corporation 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption
AU2003279877B2 (en) 2002-10-07 2010-05-20 The Regents Of The University Of California Modulation of anxiety through blockade of anandamide hydrolysis
FR2860514A1 (fr) 2003-10-03 2005-04-08 Sanofi Synthelabo Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
MX2007007428A (es) * 2004-12-24 2007-07-16 Astrazeneca Ab Compuestos heterociclicos, antagonistas de ccr2b.
WO2012058115A2 (en) * 2010-10-28 2012-05-03 Benjamin Cravatt Anti-cancer serine hydrolase inhibitory carbamates
KR102614646B1 (ko) * 2023-02-23 2023-12-19 주식회사 에이젠코어 원반형 유리관 내에 삼중수소에 의한 발광을 위한 형광층을 형성하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612186B1 (fr) * 1987-03-09 1989-07-21 Poudres & Explosifs Ste Nale Carbonyl 2,2' bis (alkyl-4 oxadiazolidines-1,2,4-diones-3,5), leur procede de preparation et leur utilisation comme intermediaires de synthese dans la preparation de carbamates
PH27613A (en) * 1987-06-25 1993-08-31 Lilly Co Eli Improvements in or relating to carbamate derivatives

Also Published As

Publication number Publication date
KR910009644A (ko) 1991-06-28
NZ236061A (en) 1993-02-25
IE904114A1 (en) 1991-05-22
AU6653490A (en) 1991-07-18
GB2238542B (en) 1993-09-01
AU635087B2 (en) 1993-03-11
FI905558A7 (fi) 1991-05-16
FI905558L (fi) 1991-05-16
CA2029934A1 (en) 1991-05-16
PT95869A (pt) 1991-09-13
HU207842B (en) 1993-06-28
JPH03206071A (ja) 1991-09-09
IL95994A0 (en) 1991-07-18
GB9024693D0 (en) 1991-01-02
EP0428385A1 (en) 1991-05-22
FI905558A0 (fi) 1990-11-09
GB2238542A (en) 1991-06-05

Similar Documents

Publication Publication Date Title
HUT54999A (en) Process for producing imidazolyl-alkenic acids and pharmaceutical compositions containing them as active components
HUT59161A (en) Process for producing serine-protease inhibitors and pharmaceutical compositions containing them
HUT56538A (en) Process for producing biologically effective 19-nor-d vitamin compounds and pharmaceutical compositions comprising such compounds
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
AU2569192A (en) Process for alkoxylation of esters and products produced therefrom
HUT58304A (en) Process for producing quinazolin-3-alkane-acids and pharmaceutical compositions containing them
HUT54364A (en) Process for producing tetrazol derivative and pharmaceutical compositions containing them
HU200177B (en) Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
AU6881791A (en) Mammalian pancreatic cholesterol esterase
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
HUT53088A (en) Process for producing ester of 1-benzyl-3-hydroxy-methyl-indazol and aliphatic 2-hydroxy-acids and pharmaceutical compositions containing them
HUT54695A (en) Process for producing new acetylcholinesteraze inhibitors and pharmaceutical compositions containing them
HUT50473A (en) Process for producing imidazopyridazinones and pharmaceutical compositions comprising such compounds
HUT54378A (en) Process for producing squalene-synthetaze inhibitors containing phosphours and pharmaceutical compositions containing them
HUT55352A (en) Process for producing compounds inhibiting cholesterol ester hydrolase enzyme and pharmaceutical compositions comprising such compounds
HUP9700810A3 (en) Acids and esters of diosmetin and pharmaceutical compositions containing them
HUT58102A (en) Process for producing quinolidine derivatives and pharmaceutical compositions comprising such compounds
HUT56552A (en) Process for producing heterocyclic oxophthalazinylacetic acids and pharmaceutical compositions comprising such compounds
ZA966154B (en) Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them
HUT55758A (en) Process for producing pyridine derivatives and pharmaceutical compositions comprising such compounds
HUT49867A (en) Process for producing new benzodioxole derivatives and pharmaceutical compositions comprising such compounds
HU9400325D0 (en) Process for producing amino-ascorbic acid derivatives and pharmaceutical compositions containing them
IL148976A (en) Process for the preparation of heteroarylcarboxylic amines and esters and some such novel compounds
ZA961843B (en) Process for the preparation of esters of stilbenedi-carboxylic acid
HUT49604A (en) Process for producing guanidinecarboxylic acid esters and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee